Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1978 1
1981 1
1986 1
1987 3
1988 4
1989 2
1990 3
1991 5
1992 1
1993 8
1994 7
1995 8
1996 2
1997 5
1998 1
1999 2
2000 4
2001 6
2002 3
2003 2
2004 13
2005 6
2006 7
2007 3
2008 3
2009 3
2010 9
2011 14
2012 10
2013 8
2014 9
2015 11
2016 5
2017 13
2018 12
2019 5
2020 11
2021 12
2022 11
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

219 results

Results by year

Filters applied: . Clear all
Page 1
Antimicrobial Resistance in Listeria Species.
Luque-Sastre L, Arroyo C, Fox EM, McMahon BJ, Bai L, Li F, Fanning S. Luque-Sastre L, et al. Among authors: arroyo c. Microbiol Spectr. 2018 Jul;6(4). doi: 10.1128/microbiolspec.ARBA-0031-2017. Microbiol Spectr. 2018. PMID: 30027884 Free article. Review.
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
Werth VP, Furie RA, Romero-Diaz J, Navarra S, Kalunian K, van Vollenhoven RF, Nyberg F, Kaffenberger BH, Sheikh SZ, Radunovic G, Huang X, Clark G, Carroll H, Naik H, Gaudreault F, Meyers A, Barbey C, Musselli C, Franchimont N; LILAC Trial Investigators. Werth VP, et al. N Engl J Med. 2022 Jul 28;387(4):321-331. doi: 10.1056/NEJMoa2118024. N Engl J Med. 2022. PMID: 35939578 Clinical Trial.
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.
Furie RA, van Vollenhoven RF, Kalunian K, Navarra S, Romero-Diaz J, Werth VP, Huang X, Clark G, Carroll H, Meyers A, Musselli C, Barbey C, Franchimont N; LILAC Trial Investigators. Furie RA, et al. N Engl J Med. 2022 Sep 8;387(10):894-904. doi: 10.1056/NEJMoa2118025. N Engl J Med. 2022. PMID: 36069871 Clinical Trial.
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial.
Fleischmann R, Mysler E, Hall S, Kivitz AJ, Moots RJ, Luo Z, DeMasi R, Soma K, Zhang R, Takiya L, Tatulych S, Mojcik C, Krishnaswami S, Menon S, Smolen JS; ORAL Strategy investigators. Fleischmann R, et al. Lancet. 2017 Jul 29;390(10093):457-468. doi: 10.1016/S0140-6736(17)31618-5. Epub 2017 Jun 16. Lancet. 2017. PMID: 28629665 Clinical Trial.
Malignant Infantile osteopetrosis.
Vomero A, Tapie A, Arroyo C, Raggio V, Peluffo G, Dufort G. Vomero A, et al. Among authors: arroyo c. Rev Chil Pediatr. 2019 Aug;90(4):443-447. doi: 10.32641/rchped.v90i4.987. Rev Chil Pediatr. 2019. PMID: 31859718 Free article. English, Spanish.
UV-C inactivation of Cronobacter sakazakii.
Arroyo C, Gayán E, Pagán R, Condón S. Arroyo C, et al. Foodborne Pathog Dis. 2012 Oct;9(10):907-14. doi: 10.1089/fpd.2012.1178. Epub 2012 Sep 18. Foodborne Pathog Dis. 2012. PMID: 22989171
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.
Corey L, Gilbert PB, Juraska M, Montefiori DC, Morris L, Karuna ST, Edupuganti S, Mgodi NM, deCamp AC, Rudnicki E, Huang Y, Gonzales P, Cabello R, Orrell C, Lama JR, Laher F, Lazarus EM, Sanchez J, Frank I, Hinojosa J, Sobieszczyk ME, Marshall KE, Mukwekwerere PG, Makhema J, Baden LR, Mullins JI, Williamson C, Hural J, McElrath MJ, Bentley C, Takuva S, Gomez Lorenzo MM, Burns DN, Espy N, Randhawa AK, Kochar N, Piwowar-Manning E, Donnell DJ, Sista N, Andrew P, Kublin JG, Gray G, Ledgerwood JE, Mascola JR, Cohen MS; HVTN 704/HPTN 085 and HVTN 703/HPTN 081 Study Teams. Corey L, et al. N Engl J Med. 2021 Mar 18;384(11):1003-1014. doi: 10.1056/NEJMoa2031738. N Engl J Med. 2021. PMID: 33730454 Free PMC article. Clinical Trial.
Resident-Led Research Policy and Power (RRPP): A Framework for Centering Community Voice in Participatory Research.
Hill Z, Taylor S, Kolack D, Maldonado G, Davis B, Medina B, Arias M, Arroyo C, Cotton S, de la Cruz M, Donadelle A, Martinez M, Starks-Payne C, Perez M, Sanchez C, Jimenez R, Abdul-Mateen Z, Bogard K. Hill Z, et al. Among authors: arroyo c. J Urban Health. 2022 Aug;99(4):688-691. doi: 10.1007/s11524-022-00646-2. Epub 2022 Jun 29. J Urban Health. 2022. PMID: 35768689 Free PMC article. No abstract available.
219 results